Terpenes in the management of chronic kidney disease

被引:1
|
作者
Kulkarni, Piyusha [1 ]
Yeram, Pranali B. [1 ]
Vora, Amisha [1 ]
机构
[1] Shri Vile Parle Kelavani Mandals Narsee Monjee Ins, Shobhaben Pratapbhai Patel Sch Pharm & Technol Man, Mumbai 400056, India
关键词
Chronic kidney disease (CKD); Terpenes; Renal dysfunction; Acute Kidney Disease (AKI); GLYCATION END-PRODUCTS; DIABETES-MELLITUS; OXIDATIVE STRESS; ANTIINFLAMMATORY ACTIVITY; HYPERTENSION; INJURY; INFLAMMATION; COMPLICATIONS; HYPERGLYCEMIA; EPIDEMIOLOGY;
D O I
10.1007/s00210-024-03098-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Chronic kidney disease (CKD) is a chronic and progressive systemic condition that characterizes irreversible alterations in the kidneys' function and structure over an extended period, spanning months to years. CKD is the one of the major causes of mortality worldwide. However, very limited treatment options are available in the market for management of the CKD. Diabetes and hypertension are the key risk factors for the progression of CKD. It is majorly characterised by glomerulosclerosis, tubular atrophy, and interstitial fibrosis. Plants are considered safe and effective in treating various chronic conditions. A diverse group of phytoconstituents, including polyphenols, flavonoids, alkaloids, tannins, saponins, and terpenes, have found significant benefits in managing chronic ailments. Terpenes constitute a diverse group of plant compounds with various therapeutic benefits. Evidence-based pharmacological studies underscore the crucial role played by terpenes in preventing and managing CKD. These substances demonstrate the capacity to hinder detrimental pathways, such as oxidative stress, inflammation and fibrosis, thereby demonstrating benefit in renal dysfunction. This review offers a comprehensive overview of the roles and positive attributes of commonly occurring terpenes in managing the causes and risk factors of CKD and the associated conditions.
引用
收藏
页码:6351 / 6368
页数:18
相关论文
共 50 条
  • [31] MANAGEMENT AND TREATMENT OF Chronic Kidney Disease
    Kopyt, Nelson
    NURSE PRACTITIONER, 2007, 32 (11): : 14 - 23
  • [32] Handbook of Chronic Kidney Disease Management
    Tranter, Shelley
    RENAL SOCIETY OF AUSTRALASIA JOURNAL, 2011, 7 (03) : 140 - 140
  • [33] Update on the Management of Chronic Kidney Disease
    Rivera, Josette A.
    O'Hare, Ann M.
    Harper, G. Michael
    AMERICAN FAMILY PHYSICIAN, 2012, 86 (08) : 749 - 754
  • [34] Hypertension management in chronic kidney disease
    Liddell, Toddra S.
    Henry-Okafor, Queen
    Umeukeje, Ebele M.
    NURSE PRACTITIONER, 2024, 49 (07): : 13 - 20
  • [35] Chronic kidney disease awareness and updates on the management of diabetic kidney disease
    Hamza, Wigdan
    Burton, James O.
    PRACTICAL DIABETES, 2023, 40 (03) : 16 - 20
  • [36] Systematic approach for the management of chronic kidney disease: moving beyond chronic kidney disease classification
    Burgos-Calderon, Rafael
    Depine, Santos
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2010, 19 (02): : 208 - 213
  • [37] Management of peripheral arterial disease in chronic kidney disease
    O'Hare, AM
    CARDIOLOGY CLINICS, 2005, 23 (03) : 225 - +
  • [38] Multiple risk factor intervention in chronic kidney disease: Management of cardiac disease in chronic kidney disease patients
    Curtis, BM
    Levin, A
    Parfrey, PS
    MEDICAL CLINICS OF NORTH AMERICA, 2005, 89 (03) : 511 - +
  • [39] Hypertension management in patients with chronic kidney disease
    Palmer, Biff F.
    CURRENT HYPERTENSION REPORTS, 2008, 10 (05) : 367 - 373
  • [40] Management of Hypertension in Patients with Chronic Kidney Disease
    Seyed Mehrdad Hamrahian
    Current Hypertension Reports, 2017, 19